Ganirelix Acetate
Payments companies reported to CMS as associated with Ganirelix Acetate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ganirelix Acetate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ganirelix Acetate
These are the largest totals companies reported as associated with Ganirelix Acetate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Karina Stroker | Warrington, PA | Family | $1,111.93 |
| Michael Grossman | Latham, NY | Reproductive Endocrinology | $752.75 |
| Rebecca Eskin | Latham, NY | $741.40 | |
| Anupama Kathiresan | Santa Monica, CA | Reproductive Endocrinology | $740.35 |
| Akas Jain | Westerville, OH | Reproductive Endocrinology | $668.44 |
| Joshua Berger | Manhattan Beach, CA | Obstetrics & Gynecology | $667.46 |
| Niccole Davey | Latham, NY | Family | $662.97 |
| Mackenzie Purdy | Creve Coeur, MO | Reproductive Endocrinology | $646.48 |
| Maurice Peress | Boca Raton, FL | Reproductive Endocrinology | $623.77 |
| Christopher Sipe | Glenview, IL | Reproductive Endocrinology | $608.56 |
Prescribed Ganirelix Acetate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.